Home
/ MangoRx
/ Competitors

MangoRx Competitors and Similar CompaniesClear all

MangoRx's competitors and similar companies include Aoxing Pharmaceutical, AOP Orphan Pharmaceuticals, Grupo Menarini and Medochemie.

	MangoRx MangoRX (also known as Mangoceuticals) is a company that provides wellness products for men.	Aoxing Pharmaceutical Aoxing Pharmaceutical is a specialty pharmaceutical company.	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	Medochemie Medochemie is a pharmaceutical company.
Founding Date	Founding Date 2021	Founding Date 2002	Founding Date 1996	Founding Date 1961	Founding Date 1976
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Dallas, US HQ	Locations Shijiazhuang Shi, CN HQ Shijiazhuang Shi, CN Foster City, US	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more	Locations Badalona, ES HQ	Locations Λεμεσός, CY HQ Ben Aknoun, DZ Amman, JO Rīga, LV Chișinău, MD Moscow, RU
Employees	Employees 2	Employees 346	Employees 5352% increase	Employees 5541% increase	Employees 825
Valuation ($)	Valuation ($) 5.8 m	Valuation ($) 5.6 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $456k (FY, 2025)	Revenue (est.) $32.3m (FY, 2016)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $54.4k (FY, 2025)	Cost of goods $7.8m (FY, 2016)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $250.4k (FY, 2025)	Gross profit $24.6m (FY, 2016)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($20.6m) (FY, 2025)	Net income $2.1m (FY, 2016)	Net income N/A	Net income N/A	Net income N/A